<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               CLINICAL PHARMACOLOGY<BR>               <BR>                  There is evidence that the metabolism of fluorouracil in the anabolic pathway blocks the methylation reaction of deoxyuridylic acid to thymidylic acid.  In this manner, fluorouracil interferes with the synthesis of deoxyribonucleic acid (DNA) and to a lesser extent inhibits the formation of ribonucleic acid (RNA).  Since DNA and RNA are essential to cell division and growth, the effect of fluorouracil may be to create a thymine deficiency which provokes unbalanced growth and death of the cell.  The effects of DNA and RNA deprivation are most marked on those cells which grow more rapidly and which take up fluorouracil at a more rapid rate.<BR>                  Following intravenous injection, fluorouracil distributes into tumors, intestinal mucosa, bone marrow, liver and other tissues throughout the body.  In spite of its limited lipid solubility, fluorouracil diffuses readily across the blood-brain barrier and distributes into cerebrospinal fluid and brain tissue.<BR>                  Seven to 20 percent of the parent drug is excreted unchanged in the urine in 6 hours; of this, over 90% is excreted in the first hour.  The remaining percentage of the administered dose is metabolized, primarily in the liver.  The catabolic metabolism of fluorouracil results in degradation products (e.g., CO2, urea and α-fluoro-ß-alanine) which are inactive.  The inactive metabolites are excreted in the urine over the next 3 to 4 hours.  When fluorouracil is labeled in the six carbon position, thus preventing the 14C metabolism to CO2, approximately 90% of the total radioactivity is excreted in the urine.  When fluorouracil is labeled in the two carbon position, approximately 90% of the total radioactivity is excreted in expired CO2.  Ninety percent of the dose is accounted for during the first 24 hours following intravenous administration.<BR>                  Following intravenous administration of fluorouracil, the mean half-life of elimination from plasma is approximately 16 minutes, with a range of 8 to 20 minutes, and is dose dependent.  No intact drug can be detected in the plasma 3 hours after an intravenous injection.<BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>